Medicure Total Current Liabilities vs Property Plant And Equipment Net Analysis

MPH Stock

CAD 0.65 0.10 13.33%

Medicure financial indicator trend analysis is infinitely more than just investigating Medicure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medicure is a good investment. Please check the relationship between Medicure Total Current Liabilities and its Property Plant And Equipment Net accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Current Liabilities vs Property Plant And Equipment Net

Total Current Liabilities vs Property Plant And Equipment Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medicure Total Current Liabilities account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have strong relationship.

The correlation between Medicure's Total Current Liabilities and Property Plant And Equipment Net is 0.78. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of Medicure, assuming nothing else is changed. The correlation between historical values of Medicure's Total Current Liabilities and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Medicure are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Total Current Liabilities i.e., Medicure's Total Current Liabilities and Property Plant And Equipment Net go up and down completely randomly.

Correlation Coefficient

0.78

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Medicure balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Medicure are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most indicators from Medicure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medicure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Medicure's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to about 30.2 K in 2025, whereas Enterprise Value Over EBITDA is likely to drop 4.46 in 2025.

	2022	2023	2024	2025 (projected)
Total Revenue	23.1M	21.7M	24.9M	26.2M
Depreciation And Amortization	2.1M	2.2M	2.5M	2.6M

Total Revenue Depreciation And Amortization

Medicure fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Inventory	Other Stockholder Equity	Intangible Assets	Non Currrent Assets Other	Other Assets	Non Current Liabilities Total	Short Long Term Debt Total	Short Term Debt	Other Current Liab	Other Liab
Total Assets		0.97	0.72	0.78	0.54	0.16	0.6	0.84	0.4	0.55	0.6	0.9	0.9	0.77	0.37	0.88	0.83	-0.18	0.77	0.39	0.52	0.78	0.71	0.06	0.88	0.82
Total Current Liabilities	0.97		0.63	0.78	0.62	0.09	0.41	0.83	0.19	0.64	0.6	0.96	0.91	0.73	0.39	0.8	0.79	-0.2	0.77	0.5	0.45	0.79	0.7	0.06	0.95	0.82
Total Stockholder Equity	0.72	0.63		0.18	-0.18	0.48	0.75	0.25	0.7	0.69	0.52	0.66	0.34	0.96	0.24	0.78	0.44	-0.19	0.16	0.58	0.89	0.15	0.06	-0.33	0.54	0.21
Property Plant And Equipment Net	0.78	0.78	0.18		0.86	-0.03	0.31	0.99	0.04	0.05	0.3	0.6	0.94	0.22	0.16	0.65	0.89	-0.12	1.0	-0.11	-0.11	0.96	0.92	0.27	0.68	0.96
Net Debt	0.54	0.62	-0.18	0.86		-0.38	-0.13	0.86	-0.31	0.0	0.21	0.5	0.85	-0.05	0.25	0.27	0.59	0.02	0.88	-0.08	-0.29	0.92	0.92	0.48	0.64	0.9
Retained Earnings	0.16	0.09	0.48	-0.03	-0.38		0.42	-0.04	0.3	0.21	-0.43	0.12	-0.1	0.33	-0.71	0.25	0.11	-0.21	-0.06	0.17	0.27	-0.19	-0.09	-0.03	0.05	-0.13
Cash	0.6	0.41	0.75	0.31	-0.13	0.42		0.34	0.91	0.13	0.39	0.29	0.33	0.65	0.12	0.78	0.56	-0.17	0.28	-0.03	0.56	0.26	0.2	-0.18	0.22	0.31
Non Current Assets Total	0.84	0.83	0.25	0.99	0.86	-0.04	0.34		0.1	0.12	0.35	0.67	0.97	0.3	0.23	0.68	0.88	-0.11	0.99	-0.03	-0.01	0.98	0.93	0.28	0.74	0.98
Cash And Short Term Investments	0.4	0.19	0.7	0.04	-0.31	0.3	0.91	0.1		0.04	0.33	0.1	0.1	0.59	0.2	0.58	0.26	-0.1	0.02	-0.06	0.66	0.05	0.0	-0.18	0.03	0.09
Net Receivables	0.55	0.64	0.69	0.05	0.0	0.21	0.13	0.12	0.04		0.5	0.82	0.31	0.82	0.3	0.4	0.17	-0.12	0.04	0.98	0.73	0.09	0.02	-0.19	0.72	0.15
Common Stock Shares Outstanding	0.6	0.6	0.52	0.3	0.21	-0.43	0.39	0.35	0.33	0.5		0.58	0.48	0.63	0.88	0.64	0.49	-0.11	0.29	0.39	0.51	0.37	0.17	-0.37	0.51	0.39
Other Current Assets	0.9	0.96	0.66	0.6	0.5	0.12	0.29	0.67	0.1	0.82	0.58		0.79	0.79	0.37	0.68	0.63	-0.15	0.6	0.71	0.55	0.64	0.57	0.05	0.98	0.68
Total Liab	0.9	0.91	0.34	0.94	0.85	-0.1	0.33	0.97	0.1	0.31	0.48	0.79		0.44	0.34	0.69	0.84	-0.11	0.94	0.16	0.15	0.97	0.92	0.29	0.86	0.98
Total Current Assets	0.77	0.73	0.96	0.22	-0.05	0.33	0.65	0.3	0.59	0.82	0.63	0.79	0.44		0.38	0.74	0.43	-0.18	0.2	0.72	0.91	0.24	0.15	-0.22	0.68	0.31
Common Stock	0.37	0.39	0.24	0.16	0.25	-0.71	0.12	0.23	0.2	0.3	0.88	0.37	0.34	0.38		0.33	0.2	0.07	0.18	0.26	0.37	0.29	0.1	-0.28	0.33	0.28
Accounts Payable	0.88	0.8	0.78	0.65	0.27	0.25	0.78	0.68	0.58	0.4	0.64	0.68	0.69	0.74	0.33		0.86	-0.28	0.63	0.2	0.49	0.58	0.46	-0.24	0.61	0.63
Inventory	0.83	0.79	0.44	0.89	0.59	0.11	0.56	0.88	0.26	0.17	0.49	0.63	0.84	0.43	0.2	0.86		-0.23	0.87	-0.02	0.09	0.8	0.7	-0.02	0.62	0.82
Other Stockholder Equity	-0.18	-0.2	-0.19	-0.12	0.02	-0.21	-0.17	-0.11	-0.1	-0.12	-0.11	-0.15	-0.11	-0.18	0.07	-0.28	-0.23		-0.09	-0.06	-0.09	-0.05	-0.04	-0.03	-0.12	-0.07
Intangible Assets	0.77	0.77	0.16	1.0	0.88	-0.06	0.28	0.99	0.02	0.04	0.29	0.6	0.94	0.2	0.18	0.63	0.87	-0.09		-0.11	-0.12	0.97	0.93	0.29	0.68	0.96
Non Currrent Assets Other	0.39	0.5	0.58	-0.11	-0.08	0.17	-0.03	-0.03	-0.06	0.98	0.39	0.71	0.16	0.72	0.26	0.2	-0.02	-0.06	-0.11		0.69	-0.05	-0.09	-0.16	0.63	0.01
Other Assets	0.52	0.45	0.89	-0.11	-0.29	0.27	0.56	-0.01	0.66	0.73	0.51	0.55	0.15	0.91	0.37	0.49	0.09	-0.09	-0.12	0.69		-0.04	-0.1	-0.22	0.45	0.02
Non Current Liabilities Total	0.78	0.79	0.15	0.96	0.92	-0.19	0.26	0.98	0.05	0.09	0.37	0.64	0.97	0.24	0.29	0.58	0.8	-0.05	0.97	-0.05	-0.04		0.97	0.39	0.74	1.0
Short Long Term Debt Total	0.71	0.7	0.06	0.92	0.92	-0.09	0.2	0.93	0.0	0.02	0.17	0.57	0.92	0.15	0.1	0.46	0.7	-0.04	0.93	-0.09	-0.1	0.97		0.55	0.7	0.97
Short Term Debt	0.06	0.06	-0.33	0.27	0.48	-0.03	-0.18	0.28	-0.18	-0.19	-0.37	0.05	0.29	-0.22	-0.28	-0.24	-0.02	-0.03	0.29	-0.16	-0.22	0.39	0.55		0.2	0.38
Other Current Liab	0.88	0.95	0.54	0.68	0.64	0.05	0.22	0.74	0.03	0.72	0.51	0.98	0.86	0.68	0.33	0.61	0.62	-0.12	0.68	0.63	0.45	0.74	0.7	0.2		0.78
Other Liab	0.82	0.82	0.21	0.96	0.9	-0.13	0.31	0.98	0.09	0.15	0.39	0.68	0.98	0.31	0.28	0.63	0.82	-0.07	0.96	0.01	0.02	1.0	0.97	0.38	0.78

Click cells to compare fundamentals

Medicure Account Relationship Matchups

Medicure fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	34.1M	28.4M	29.9M	28.1M	32.3M	39.2M
Total Current Liabilities	12.3M	8.5M	8.4M	7.9M	9.1M	13.3M
Total Stockholder Equity	19.1M	18.4M	21.0M	19.9M	22.9M	15.4M
Property Plant And Equipment Net	1.6M	1.6M	1.2M	736K	846.4K	888.0K
Net Debt	(1.3M)	(2.5M)	(4.0M)	(5.8M)	(6.7M)	(6.4M)
Retained Earnings	(65.6M)	(66.3M)	(64.9M)	(65.9M)	(59.3M)	(62.2M)
Cash	2.7M	3.7M	4.9M	6.4M	5.7M	6.8M
Non Current Assets Total	18.4M	15.9M	15.1M	12.9M	14.8M	16.1M
Cash And Short Term Investments	2.7M	3.7M	4.9M	6.4M	5.7M	8.7M
Net Receivables	5.3M	4.7M	5.6M	4.8M	5.5M	7.7M
Common Stock Shares Outstanding	15.0M	10.7M	10.3M	10.4M	12.0M	10.8M
Liabilities And Stockholders Equity	34.1M	28.4M	29.9M	28.1M	32.3M	40.7M
Other Current Assets	2.6M	872K	1.1M	1.1M	1.3M	2.0M
Total Liab	14.9M	10.0M	8.9M	8.2M	9.4M	8.9M
Total Current Assets	15.7M	12.6M	14.8M	15.2M	17.5M	23.7M
Common Stock	122.9M	85.4M	80.9M	81.0M	93.2M	98.8M
Accounts Payable	7.0M	6.7M	7.1M	7.2M	8.3M	5.7M
Inventory	5.1M	3.3M	3.2M	2.9M	3.3M	2.4M
Other Stockholder Equity	10.3M	10.4M	10.5M	10.7M	9.7M	9.2M
Intangible Assets	13.6M	11.2M	10.6M	8.9M	10.3M	10.5M
Non Currrent Assets Other	156K	57K	63K	75K	67.5K	64.1K
Other Assets	12.2M	39K	156K	57K	65.6K	62.3K
Accumulated Other Comprehensive Income	(6.5M)	(6.6M)	(5.5M)	(6.0M)	(5.4M)	(5.1M)
Non Current Liabilities Total	2.6M	1.5M	503K	229K	206.1K	195.8K
Short Long Term Debt Total	1.4M	1.2M	849K	544K	489.6K	465.1K
Short Term Debt	367K	380K	346K	315K	283.5K	269.3K
Other Current Liab	2.3M	716K	179K	382K	343.8K	326.6K
Other Liab	3.2M	2.8M	1.5M	696K	626.4K	595.1K
Net Tangible Assets	81.9M	17.3M	2.6M	4.2M	4.9M	7.8M
Property Plant Equipment	316K	1.3M	1.6M	1.6M	1.9M	1.9M
Current Deferred Revenue	2.7M	748K	737K	16K	18.4K	17.5K
Capital Lease Obligations	1.4M	1.2M	849K	544K	625.6K	853.2K
Non Current Liabilities Other	3.2M	1.2M	386K	105K	94.5K	89.8K
Net Invested Capital	19.1M	18.4M	21.0M	19.9M	17.9M	30.8M
Net Working Capital	3.4M	4.0M	6.5M	7.3M	6.5M	6.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medicure Stock Analysis

When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC